- Today
- Holidays
- Birthdays
- Reminders
- Cities
- Atlanta
- Austin
- Baltimore
- Berwyn
- Beverly Hills
- Birmingham
- Boston
- Brooklyn
- Buffalo
- Charlotte
- Chicago
- Cincinnati
- Cleveland
- Columbus
- Dallas
- Denver
- Detroit
- Fort Worth
- Houston
- Indianapolis
- Knoxville
- Las Vegas
- Los Angeles
- Louisville
- Madison
- Memphis
- Miami
- Milwaukee
- Minneapolis
- Nashville
- New Orleans
- New York
- Omaha
- Orlando
- Philadelphia
- Phoenix
- Pittsburgh
- Portland
- Raleigh
- Richmond
- Rutherford
- Sacramento
- Salt Lake City
- San Antonio
- San Diego
- San Francisco
- San Jose
- Seattle
- Tampa
- Tucson
- Washington
Capital International Inc. CA Takes Position in Johnson & Johnson
The investment firm bought 32,298 shares of the healthcare giant in the third quarter.
Mar. 12, 2026 at 8:08am
Got story updates? Submit your updates here. ›
Capital International Inc. CA, an investment management firm, disclosed in a recent SEC filing that it bought a new position in shares of Johnson & Johnson (NYSE: JNJ) during the third quarter of 2026. The firm purchased 32,298 shares of the company's stock, valued at approximately $5,989,000.
Why it matters
Johnson & Johnson is one of the world's largest and most diversified healthcare companies, with a presence across pharmaceuticals, medical devices, and consumer health products. The fact that a major investment firm like Capital International has taken a position in JNJ shares suggests confidence in the company's long-term growth prospects.
The details
According to the SEC filing, Capital International Inc. CA bought the 32,298 shares of Johnson & Johnson stock in the third quarter of 2026. This represents a new position for the investment firm in the healthcare giant. The shares were valued at approximately $5,989,000 based on JNJ's stock price at the time.
- Capital International Inc. CA bought the shares in the third quarter of 2026.
The players
Capital International Inc. CA
An investment management firm that recently took a new position in shares of Johnson & Johnson.
Johnson & Johnson
A multinational healthcare company that develops, manufactures, and markets pharmaceutical, medical device, and consumer health products.
The takeaway
The decision by Capital International Inc. CA to establish a new position in Johnson & Johnson shares reflects the investment firm's confidence in the healthcare company's long-term growth potential. As one of the world's largest and most diversified healthcare conglomerates, JNJ's stock continues to be a popular choice among institutional investors.
